AUS
NZ
UK
CA
USA
IND
Healthcare
Meihua (MHUA) stock down 10% after Wednesday’s rally in Nasdaq debut
February 17, 2022 08:39 AM PST| By Versha JainHighlights China-based Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA) debuted on Nasdaq Wednesday. The IPO was priced at US$10.00 per share. The stock was up 29% on first-day trading. The China-based Meihua is the fir.....
Why Masimo (MASI) stock plunged 37% today?
February 16, 2022 04:04 PM PST| By Versha JainHighlights Masimo Corporation (NASDAQ: MASI) revenue increased by 8.3% in fiscal 2021. The medical technology company is acquiring Sound United for US$1.025 billion. Masimo’s product revenue grew by 11.0% YoY to US$327.6 million .....
Why BioDelivery Sciences (BDSI) stock soared 51% today?
February 14, 2022 09:08 AM PST| By Rupam RoyHighlights BioDelivery (BDSI) has entered into a merger agreement with Collegium Pharmaceutical. Collegium will acquire all outstanding BDSI shares at US$5.60 per unit in an all-cash deal. The BDSI stock surged over 14% YTD. Stocks of Bio.....
Top S&P 500 healthcare stocks to watch
February 09, 2022 04:10 PM PST| By Rupam RoyHighlights Johnson & Johnson’s (NYSE: JNJ) total sales surged over 10% YoY in Q4, FY21. Pfizer, Inc. (NYSE: PFE) revenue soared 105% YoY in Q4, FY21. Eli Lilly and Company (NYSE: LLY) revenue grew 15% YoY in fiscal 2021. The US .....
Pfizer Inc’s (PFE) 2022 vaccine sales outlook falls short of estimates
February 08, 2022 11:46 AM PST| By Versha JainHighlights Pfizer, Inc’s (NYSE: PFE) fiscal 2021-revenue skyrocketed by 95% YoY to US$81.3 billion. Excluding Covid-19 vaccines, the revenue rose around 6% last year on a YoY basis. Pfizer raised the full-year revenue guidance in the ran.....
Can Nuvectis Pharma’s (NVCT) product pipeline, price sway investors?
February 08, 2022 09:14 AM PST| By Versha JainHighlights Nuvectis Pharma Inc. (NASDAQ: NVCT) debuted on Nasdaq on February 4, 2022. The stock gained 144.62% gain on February 7. Nuvectis plans to use the proceeds to fund the development of product candidates, such as NXP800, NXP900.....
Amgen Inc (AMGN) CEO Bradway upbeat on growth prospects after results
February 07, 2022 03:47 PM PST| By Versha JainHighlights Amgen Inc. (NASDAQ: AMGN) revenue grew 2% to US$26.0 billion in fiscal 2021. Its non-GAAP EPS was US$17.10, up 6% YoY, driven by higher revenue and lower expenses. The stock fell 5.9% in one year. Pharma major Amg.....
Top 7 healthcare stocks on NASDAQ to consider
February 03, 2022 12:23 PM PST| By Versha JainHighlights The Omicron virus has renewed focus on the healthcare sector. WHO has warned not to let the guards despite lower hospitalization rate. The Nasdaq Biotechnology Index fell around 19% in one year. The .....
Merck & Company (MRK) bets big on ‘molnupiravir’, raises guidance
February 03, 2022 11:35 AM PST| By Rupam RoyHighlights The company expects an 18% jump in sales in 2022. Covid pill molnupiravir sales are expected to be US$5 billion to US$6 billion in 2022. Merck & Company's revenue surged 24% YoY to US$13.52 billion In the fourth quarter. Me.....
SOC Telemed (TLMD) stock roars 342% higher after purchase offer
February 03, 2022 09:36 AM PST| By Rupam RoyHighlights SOC Telemed has entered into a definitive agreement to be acquired by Patient Square Capital. Telemed shareholders will receive US$3 in cash for each Class A common stock. The transaction is expected to close in the second quarter o.....
Why has Doximity (DOCS) stock declined & what’s next?
February 03, 2022 07:24 AM PST| By Rupam RoyThe Doximity, Inc. (NYSE: DOCS) stock has declined sharply from its 52-week high of US$107.79 in September 2021. The company debuted in the US stock market in June last year. The San Francisco-based telehealth company offers online services like v.....
.jpg)
Moderna (MRNA) gets full approval for Spikevax, stock jumps 4.5%
January 31, 2022 01:22 PM PST| By Versha JainHighlights Moderna, Inc. (MRNA) received full FDA approval for Spikevax. The vaccine approval is for people aged 18 years and older. The stock surged more than 4.5% in the intraday session. The Moderna, Inc. (NASDAQ: MRNA) stock s.....
Why Aridis Pharmaceuticals (ARDS) soared on Thursday?
January 27, 2022 09:22 AM PST| By Rupam RoyHighlights Aridis said it received funding from Bill & Melinda Gates Foundation. The funds will be used to evaluate inhaled monoclonal antibodies. The ARDS stock returned over 30% gains in the past five days. The stocks of Aridis Phar.....
.jpg)
Why Sierra Oncology (SRRA) stock jumped 59% today?
January 25, 2022 11:39 AM PST| By Rupam RoyHighlights Sierra reported US$104.7 million in cash and cash equivalents as of December 31, 2021. Sierra Oncology, Inc. announced positive data from its clinical trial of momelotinib. Under a deal, Oxford Finance, LLC will extend a loan of US$.....
Why Aptorum Group (APM) stock jumped 33% today?
January 20, 2022 11:32 AM PST| By Rupam RoyHighlights Aptorum Group has received FDA's Orphan Drug Designation for its SACT-1 drug. The Aptorum stock surged over 33% following the news. The company now plans to file an Investigational New Drug Application to start clinical trials of SA.....
Why NeuroMetrix (NURO) stock jumped over 40% today?
January 18, 2022 10:09 AM PST| By Rupam RoyHighlights NeuroMetrix has received FDA’s breakthrough designation for its Quell technology. The NURO stock rose over 41% after the news. It gained over 32% in the past 12 months. The NeuroMetrix, Inc. (NASDAQ: NURO) stock jumped ov.....
5 best US hospital stocks for 2022
January 15, 2022 12:51 AM PST| By Versha JainThe Omicron variant caused around 98% of Covid-19 cases in the previous week in the US as per the U.S. Centers for Disease Control and Prevention estimates released Tuesday. The infections are rising fast, surpassing the surge rate in the earlier v.....
Why is iSpecimen Inc’s stock trending? ISPC spikes 13% in premarket
January 13, 2022 10:50 AM PST| By Rupam RoyHighlights iSpecimen Inc. announced the expansion of its supplier capabilities on January 13 It is adding a reference lab in New York to support its customers engaged in Covid-19 research The company's revenue rose 21% in Q3, FY21 The sto.....
Why is Immuron Limited’s shares rocketing? Pharma stock IMRN spikes 89%
January 12, 2022 10:30 AM PST| By Rupam RoyHighlights The IMRN stock rallied over 89% in pre-market trading Wednesday The company has been awarded funding of A$6.2 million (US$4.45 million) by the US Department of Defense Under the agreement, the firm will examine the dosing regimen fo.....
Why is Immix Biopharma’s (IMMX) stock soaring? IMMX up 30% in premarket
January 12, 2022 08:44 AM PST| By Versha JainHighlights Immix Biopharma, Inc. (NASDAQ: IMMX) announced the study data of its lead candidate IMX-110 January 12. The stock jumped 30.94% at 8:43 am ET in pre-market Wednesday. The company had its IPO in December 2021. Immix Biopharma, I.....
